--2026/FY-- / 1.138B--
--2025/FY-- / 862.000M--
--2024/FY419.265M / 550.000M--
--------
--------
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688488 Jiangsu Aidea Pharmaceutical
- 10.75
- +0.29+2.77%
Market Closed Apr 24 15:00 CST
4.52BMarket Cap-43.35P/E (TTM)
10.85High10.38Low105.67KlotVolume10.69Open10.46Pre Close112.43MTurnover2.51%Turnover RatioLossP/E (Static)420.78MShares17.3352wk High4.23P/B4.52BFloat Cap6.5852wk Low12.55Limit Up420.78MShs Float45.21Historical High8.37Limit Down4.49%Amplitude6.58Historical Low--Dividend TTM10.64Avg Price51.88KlotAsk--Div YieldTTM100Lot Size51.04KlotBid
Jiangsu Aidea Pharmaceutical Key Stats
Jiangsu Aidea Pharmaceutical Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Jiangsu Aidea Pharmaceutical Earnings Reports
Read more
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs